Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf M Huber

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Onkologie|December 5, 2012
Toxic epidermal necrolysis after pemetrexed and cisplatin for non-small cell lung cancer in a patient with sharp syndromeCornelia Then, Jobst C von Einem, Daniel Müller, et al.
Clinical Lung Cancer|October 10, 2006
Topotecan therapy in patients with relapsed small-cell lung cancer and poor performance statusRogerio C Lilenbaum, Rudolf M Huber, Joseph Treat, et al.
Clinical Lung Cancer|January 21, 2010
Concurrent chemoradiation therapy with docetaxel/cisplatin followed by docetaxel consolidation therapy in inoperable stage IIIA/B non-small-cell lung cancer: results of a phase I studyRudolf M Huber, Astrid Borgmeier, Michael Flentje, et al.
European Journal of Endocrinology|April 23, 2017
Assessment of lung function in a large cohort of patients with acromegalySylvère Störmann, Bodo Gutt, Josefine Roemmler-Zehrer, et al.
Chest|May 12, 2004
Detection of melanoma antigen-A expression in sputum and bronchial lavage fluid of patients with lung cancerIngo Mecklenburg, Diana F Stratakis, Rudolf M Huber, et al.
Pharmacoeconomics|June 18, 2015
Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in GermanyKatharina Schremser, Wolf H Rogowski, Sigrid Adler-Reichel, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 20, 2024
Resectable non-stage IV nonsmall cell lung cancer: the surgical perspectiveClemens Aigner, Hasan Batirel, Rudolf M Huber, et al.
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthmaEric D Bateman, Theo A Bantje, Maria João Gomes, et al.
Onkologie|April 8, 2006
Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility studyGabriele Beckmann, Rainer Fietkau, Rudolf M Huber, et al.
Onkologie|October 29, 2013
[Tumor conference II]Amanda Tufman, Christian Schumann, Rudolf M Huber, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Onkologie|December 5, 2012
Toxic epidermal necrolysis after pemetrexed and cisplatin for non-small cell lung cancer in a patient with sharp syndromeCornelia Then, Jobst C von Einem, Daniel Müller, et al.
Clinical Lung Cancer|October 10, 2006
Topotecan therapy in patients with relapsed small-cell lung cancer and poor performance statusRogerio C Lilenbaum, Rudolf M Huber, Joseph Treat, et al.
Clinical Lung Cancer|January 21, 2010
Concurrent chemoradiation therapy with docetaxel/cisplatin followed by docetaxel consolidation therapy in inoperable stage IIIA/B non-small-cell lung cancer: results of a phase I studyRudolf M Huber, Astrid Borgmeier, Michael Flentje, et al.
European Journal of Endocrinology|April 23, 2017
Assessment of lung function in a large cohort of patients with acromegalySylvère Störmann, Bodo Gutt, Josefine Roemmler-Zehrer, et al.
Chest|May 12, 2004
Detection of melanoma antigen-A expression in sputum and bronchial lavage fluid of patients with lung cancerIngo Mecklenburg, Diana F Stratakis, Rudolf M Huber, et al.
Pharmacoeconomics|June 18, 2015
Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in GermanyKatharina Schremser, Wolf H Rogowski, Sigrid Adler-Reichel, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 20, 2024
Resectable non-stage IV nonsmall cell lung cancer: the surgical perspectiveClemens Aigner, Hasan Batirel, Rudolf M Huber, et al.
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthmaEric D Bateman, Theo A Bantje, Maria João Gomes, et al.
Onkologie|April 8, 2006
Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility studyGabriele Beckmann, Rainer Fietkau, Rudolf M Huber, et al.
Onkologie|October 29, 2013
[Tumor conference II]Amanda Tufman, Christian Schumann, Rudolf M Huber, et al.
Pageof 11